Hyperphenylalaninaemia in children with falciparum malaria

QJM: An International Journal of Medicine

Volumn 92, Issue 9, 1999, Pages 495-503

  Enwonwu, C O ^a,b,f   Afolabi, B M ^c   Salako, L A ^c   Idigbe, E O ^c   Al Hassan, H ^d   Rabiu, R A ^e  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c NIGERIAN INSTITUTE OF MEDICAL RESEARCH   (Nigeria)

^d Specialist Hospital Yola Nigeria   (Nigeria)

^e Massey Street Children Hospital   (Nigeria)

^f Graduate Program in Craniofacial Biology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BRAIN MONOAMINE; DOPAMINE; HISTAMINE; NORADRENALIN; PHENYLALANINE; PHENYLALANINE 4 MONOOXYGENASE; SEROTONIN;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; FEMALE; HUMAN; HYPERPHENYLALANINEMIA; MALARIA FALCIPARUM; MALE; MONOAMINE METABOLISM; PRIORITY JOURNAL; SEROTONIN METABOLISM;

EID: 0032871032     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/92.9.495     Document Type: Article

References (68)

1. Greenwood B, Marsh K, Snow R. Why do some African children develop severe malaria. Parasitol Today 1991; 7:277-81.
2. Molyneux ME, Taylor TE, Wirima JJ, Bogstein A. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med 1989; 71:441-59.
3. Stettler N, Schutz Y, Whitehead R, Jequier E. Effect of malaria and fever on energy metabolism in Gambian children. Ped Res 1992; 31:102-6.
4. Crawley J, Smith S, Kirkham F, Muthini P, Waruiru C, Marsh K. Seizures and status epilepticus in childhood cerebral malaria. Q J Med 1996; 89:591-7.
5. Walker O, Salako LA, Sowunmi A, Thomas JO, Sodeinde O, Bondi FS. Prognostic risk factors and post-mortem findings in cerebral malaria in children. Trans Roy Soc Trop Med Hyg 1992; 86:491-3.
6. Solomons NW, Keusch GT. Nutritional implications of parasitic infections. Nutr Rev 1981; 39:149-61.
7. Beisel WR. Infection-induced malnutrition: from cholera to cytokines. Am J Clin Nutr 1995; 62:813-19.
8. Baptista JL, Vanham G, Wery M, Marck EV. Cytokine levels during mild and cerebral falciparum malaria in children living in a mesoendemic area. Trop Med Int Hlth 1997; 2:673-9.
9. Rook GAW, Hernandez-Pando R, Lightman SL. Hormones, peripherally activated prohormones, and regulation of the Th1/Th2 balance. Immunol Today 1994; 15:301-3.
10. Dekker E, Romijn JA, Moeniralam HS, Waruiru C, Ackermans MT, Timmer JG, Endert E, Peshu N, Marsh K, Sauerwein HP. The influence of alanine infusion on glucose production in 'malnourished' African children with falciparum malaria. Q J Med 1997; 90:455-60.
11. Meier CA. Mechanisms of immunosuppression by glucocorticoids. Eur J Endocrinol 1996; 134:50.
12. Sowunmi A. Hepatomegaly in acute falciparum malaria in children. Trans Roy Soc Trop Med Hyg 1996; 90:540-2.
13. Anstey NM, Granger DL, Weinberg JB. Nitrate levels in malaria. Trans Roy Soc Trop Med Hyg 1997; 91:238.
14. Desowitz RS. The pathophysiology of malaria after Maegraith. Ann Trop Med Parasitol 1987; 81:599-606.
15. Rossi-Fanelli F, Freund H, Krause R, Smith AR, Howard James J, Castorina-Ziparo S, Fischer JE. Induction of coma in normal dogs by the infusion of aromatic amino acids and its prevention by the addition of branched-chain amino acids. Gastroenterol 1982; 83:664-71.
16. Abumrad NN, Miller B. The physiology and nutritional significance of plasma free amino acid levels. J Parent Enteral Nutr 1983; 7:163-70.
17. Roy S, Chattopadhyay RN, Maitra SK. Changes in brain neurotransmitters in rodent malaria. Indian J Malariol 1993; 30:183-5.
18. Pardridge WM. Brain metabolism: A perspective from the blood-brain barrier. Physiol Rev 1983; 63:1481-535.
19. Michalak A, Butterworth RF. Selective increases of extracellular brain concentrations of aromatic and branched-chain amino acids in relation to deterioration of neurological status in acute (ischemic) liver failure. Metabol Br Dis 1997; 12:259-69.
20. Siddiqui WA, Trager W. Free amino acids of blood plasma and erythrocytes of normal ducks and ducks infected with malarial parasite, Plasmodium lophurae. Nature 1967; 214:1046-7.
21. Sherman IW. Transport of amino acids and nucleic acid precursors in malarial parasites. Bull WHO 1977; 55:211-25.
22. Warrell DA, Molyneux ME, Beales PF. Severe and Complicated Malaria. Trans Roy Soc Trop Med Hyg 1990; 84 (Supplement 2):1-65.
23. World Health Organization. Advances in Malaria Chemotherapy, Technical Report Series 711, 1984: 2-30.
24. NCHS. Growth Curves for Children from Birth to 18 years. United States Department of Health, Education and Welfare. DHEW Publication PHS 78-1650: 1977.
25. Heinrikson R, Meredith SA. Amino acid analysis by reverse-phase HPLC: precolumn derivatization with phenylisothiocyanate. Anal Biochem 1984; 136:65-74.
26. Pardridge WM. Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids. Neurochem Res 1998; 23:635-44.
27. Hargreaves KM, Pardridge WM. Neutral amino acid transport at the human blood-brain barrier. J Biol Chem 1988; 263:19392-7.
28. Enwonwu CO, Falkler WA, Idigbe EO, Afolabi BM, Ibrahim M, Onwujekwe D, Savage KO, Meeks V. Pathogenesis of cancrum oris (noma): confounding interactions of malnutrition with infection. Am J Trop Med Hyg 1999; 60:223-32.
29. Vanderjagt DJ, Garry PJ, Bhagavan HN. Ascorbic acid intake and plasma levels in healthy elderly people. Am J Clin Nutr 1987; 46:290-4.
30. Jacob RA. Assessment of human vitamin C status. J Nutr 1990; 120:1480-5.
31. DeOnis M, Monteiro C, Akre J, Clugston G. The worldwide magnitude of protein-energy malnutrition: an overview from the WHO global database on child growth. Bull WHO 1993; 71:703-12.
32. Fernstrom JD, Wurtman RJ. Brain serotonin content: physiological regulation by plasma neutral amino acids. Science 1972; 178:414-16.
33. Enwonwu CO. Amino acid availability and control of histaminergic systems in the brain, In: Huether G. ed. Amino Acid Availability and Brain Function in Health and Disease, NATO ASI Series, Vol H20, 1988:167-73.
34. Knox WE. Phenylketonuria. In: Stanbury JB, Wyngaarden JB, Fredrickson DS. eds. The Metabolic Basis of Inherited Disease. New York, McGraw-Hill, 1972:266-95.
35. Jeevanandam M. Trauma and sepsis. In: Cynober LA, ed. Amino Acid Metabolism and Therapy in Health and Nutritional Disease. Boca Raton FL, CRC Press, 1995:245-55.
36. White NJ, Ho M. The pathophysiology of malaria. Adv Parasitiol 1992; 31:83-173.
37. Scriver CR, Clow CL. Phenylketonuria: epitome of human biochemical genetics. N Engl J Med 1980; 303:1336-42.
38. Kaufman S. Regulation of the activity of hepatic phenylalanine hydroxylase. In: Weber G, ed. Advances in Enzyme Regulation, Vol. 25. Oxford, Pergamon Press, 1986:37-64.
39. Jackson AA, Crimble RF. Malnutrition and amino acid metabolism. In: Suskind RM, Lewinler-Suskind, eds. The Malnourished Child. Nestle Nutrition Workshop Series, Vol. 19. New York, Vevey/Raven Press, 1990:73-94.
40. Alleyne GAO, Hay RW, Picou DI, Stanfield JP, Whitehead RG. Protein-Energy Malnutrition. London, Edward Arnold, 1977:54-62.
41. Wannemacher, Jr. RW, Pekarek RS, Bartellon PJ, Vollmer RT, Beisel WR. Changes in individual plasma amino acids following experimentally induced sand fly fever virus infection. Metabolism 1972; 21:67-76.
42. Wannemacher Jr RW. Key role of various individual amino acids in host response to infection. Am J Clin Nutr 1977; 30:1269-80.
43. Jeevanandam M. Trauma and sepsis. In: Cynober LA, ed. Amino Acid Metabolism and Therapy in Health and Nutritional Disease. Boca Raton, CRC Press, 1995:245-55.
44. Vente JP, Von Meyenfeldt MF, Van Eijk HMH, Van Berlo CLH, Gouma DJ, Van Der Linden CJ, Soeters PB. Plasma amino acid profiles in sepsis and stress. Ann Surg 1989; 209:57-62.
45. Freund H, Atamian S, Holroyde J, Fischer J. Plasma amino acids as predictors of the severity and outcome of sepsis. Ann Surg 1979; 190:571-6.
46. Antener I, Verwilghen AM, Van Geert C, Mauron J. Biochemical study of malnutrition. VI: Histidine and its metabolites. Internat J Vit Nutr Res 1982; 53:199-209.
47. Edozien JC, Obasi ME. Protein and amino acid metabolism in kwashiorkon. Clin Sci 1965; 29:1-24.
48. Jeevanandam M, Young DH, Ramias L, Schiller WR. Aminoaciduria of severe trauma. Am J Clin Nutr 1989; 49:814-22.
49. Dhondt JL, Farriaux JP. Atypical cases of phenylketonuria. Eur J Pediatr 1987; 146:A38-43.
50. Migasena P, Areekul S. Capillary permeability function in malaria. Ann Trop Med Parasitol 1987; 81:549-60.
51. Krungkrai J, Webster HK, Yuthavong Y. De novo and salvage biosynthesis of pteroylpetaglutamates in the human malaria parasite, Plasmodium falciparum. Mol Biochem Parasitol 1989; 32:25-38.
52. Kaufman S. Tetrahydrobiopterin and hydroxylation systems in health and disease. In: Lovenberg W, Levine RA, eds. Unconjugated Pterins in Neumbiology: Basic and Clinical Aspects. London, Taylor and Francis, 1987:1-28.
53. Pollock RJ, Kaufman S. Dihydrofolate reductase is present in brain. J Neurochem 1978; 30:253-6.
54. Kaufman S, Holtzman N, Milstein S, Butler IJ, Krumholz A. Phenylketonuria due to a deficiency of dihydropteridine reductase. N Engl J Med 1975; 293:785-90.
55. Kaufman S. Phenylketonuria and its variants. In: Harris H, Hirschhorn K, eds. Advances in Human Genetics, Vol 13. New York, Plenum Press, 1983:217-97.
56. Choi TB, Pardridge WM. Phenylalanine transport at the human blood-brain barrier. Studies with isolated human brain capillaries. J Biol Chem 1986; 261:6536-41.
57. Maher TJ. Modification of synthesis, release, and function of catecholaminergic systems by phenylalanine. In: Huether G, ed. Amino Acid Availability and Brain Function in Health and Disease. NATO ASI Series, Vol. H20, 1988:201-6.
58. Loo YH. Serotonin deficiency in experimental hyperphenylalaninemia. J Neurochem 1974; 23:139-47.
59. McKean CM. The effects of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain. Brain Res 1972; 47:469-76.
60. Pardridge WM. Potential effects of the dipeptide sweetener aspartame on the brain. In: Wurtman RJ, Wurtman JJ, eds. Nutrition and the Brain, Vol. 7. New York, Raven Press, 1986:199-224.
61. Jobe PC, Ko KH, Dailey JW. Abnormalities in norepinephrine turnover rate in the central nervous system of the genetically epilepsy-prone rat. Brain Res 1984; 290:357-60.
62. Enwonwu CO, Okolie EE. Differential effects of protein malnutrition and ascorbic acid deficiency on histidine metabolism in the brain of infant nonhuman primates. J Neurochem 1983; 41:230-8.
63. Schwartz JC, Arrang JM, Garbarg M, Pollard H, Ruat M. Histaminergic transmission in the mammalian brain. Physiol Rev 1991; 71:1-51.
64. Grau GE, de Kossodo S. Cerebral malaria: mediators, mechanical obstruction or more? Parasitol Today 1994; 10:408-9.
65. Clark IA, Rockett KA. The cytokine theory of human cerebral malaria. Parasitol Today 1994; 10:410-12.
66. Thurnham DI, Singkamani R, Kaewichit R, Wongworapat K. Influence of malaria infection on peroxyl-radical trapping capacity in plasma from rural and urban Thai adults. Br J Nutr 1991; 64:257-71.
67. Centers for Diseases Control. Evaluation of Consumer Complaints Related to Aspartame Use. CDC, 1984.
68. Stegink LD. Aspartame metabolism in humans: acute dosing studies. In: Stegink LD, Filer LJ, eds. Aspartame Physiology and Biochemistry. New York, Marcel Dekker, 1984:509-53.